Counselling Patients on the PSA Blood Test
Prostate Cancer UK’s toolkit offers an overview of updated PSA test guidance per the 2019 NICE guidelines, aiming to improve diagnostic accuracy and safety, and assists healthcare professionals in discussing the test’s pros and cons with patients to support informed decision-making.
Tens of thousands fewer men face harm in prostate cancer diagnosis
Prostate Cancer UK’s new research indicates that improved scans and safer biopsies may allow the UK to launch a prostate cancer screening program, potentially reducing deaths and harms, with the National Screening Committee considering new screening proposals.
Exploring radiotherapy treatment, pathways and supportive care – a collaboration with RadChat
Prostate Cancer UK teams up with RadChat, the award-winning, first Therapeutic Radiographer-led podcast, to deliver this valuable webinar about radiotherapy in prostate cancer treatment.
Prostate Cancer Essentials: Part 2 – Diagnosing and Staging
A course providing healthcare professionals with an increased understanding of how prostate cancer is diagnosed.
Using real world data to bridge the evidence gap left by prostate cancer screening trials
How Real-World Data can demonstrate reduction in harms of prostate cancer screening and inform the future of diagnostics to improve early diagnosis.
The modern prostate cancer diagnostic pathway
Dr. Olly Hulson provides an overview of the modern prostate cancer diagnostic pathway.
PSA consensus recommendations and implications for practice
Dr. Sam Merriel presents PSA consensus recommendations and implications for practice.
Lived experience conversation
Meg Burgess, Senior Specialist Nurse at Prostate Cancer UK, leads a lived experience conversation with Tony, Junior, and Patrick.
Remote consultations: experiences of UK patients with prostate cancer during the COVID-19 pandemic
The article highlights that UK prostate cancer patients preferred in-person consultations for key discussions but accepted remote consultations for routine follow-ups, suggesting a balanced approach with critical decisions made face-to-face.
Prostate mpMRI in the UK: the state of the nation
The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.
